Pfizer Inc (PFE)
26.32
+0.06
(+0.23%)
USD |
NYSE |
Apr 23, 16:00
26.35
+0.03
(+0.11%)
Pre-Market: 08:35
Pfizer Total Assets (Quarterly): 226.50B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 226.50B |
| September 30, 2023 | 215.02B |
| June 30, 2023 | 220.17B |
| March 31, 2023 | 195.62B |
| December 31, 2022 | 197.20B |
| September 30, 2022 | 195.35B |
| June 30, 2022 | 195.29B |
| March 31, 2022 | 183.84B |
| December 31, 2021 | 181.48B |
| September 30, 2021 | 179.19B |
| June 30, 2021 | 169.92B |
| March 31, 2021 | 158.82B |
| December 31, 2020 | 154.23B |
| September 30, 2020 | 178.98B |
| June 30, 2020 | 177.93B |
| March 31, 2020 | 166.34B |
| December 31, 2019 | 167.59B |
| September 30, 2019 | 170.45B |
| June 30, 2019 | 156.20B |
| March 31, 2019 | 155.42B |
| December 31, 2018 | 159.42B |
| September 30, 2018 | 167.84B |
| June 30, 2018 | 164.98B |
| March 31, 2018 | 164.61B |
| December 31, 2017 | 171.80B |
| Date | Value |
|---|---|
| September 30, 2017 | 172.15B |
| June 30, 2017 | 168.56B |
| March 31, 2017 | 168.78B |
| December 31, 2016 | 171.62B |
| September 30, 2016 | 178.43B |
| June 30, 2016 | 170.66B |
| March 31, 2016 | 162.93B |
| December 31, 2015 | 167.38B |
| September 30, 2015 | 170.87B |
| June 30, 2015 | 160.88B |
| March 31, 2015 | 160.64B |
| December 31, 2014 | 167.57B |
| September 30, 2014 | 171.36B |
| June 30, 2014 | 172.61B |
| March 31, 2014 | 171.81B |
| December 31, 2013 | 172.10B |
| September 30, 2013 | 175.52B |
| June 30, 2013 | 179.34B |
| March 31, 2013 | 187.40B |
| December 31, 2012 | 185.80B |
| September 30, 2012 | 182.60B |
| June 30, 2012 | 182.84B |
| March 31, 2012 | 185.68B |
| December 31, 2011 | 188.00B |
| September 30, 2011 | 196.13B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
154.23B
Minimum
Dec 2020
226.50B
Maximum
Dec 2023
183.69B
Average
179.19B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 97.15B |
| Gilead Sciences Inc | 62.12B |
| Johnson & Johnson | 167.56B |
| Viking Therapeutics Inc | 368.49M |
| Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 137.21B |
| Shareholders Equity (Quarterly) | 89.01B |
| Debt to Equity Ratio | 0.7959 |
| Current Ratio | 0.9067 |
| Net Debt Paydown Yield | -4.33% |